deltatrials
Recruiting PHASE4 INTERVENTIONAL 2-arm NCT03737604

TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant

Transversus Abdominis Plane (TAP) Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine: A Prospective Randomized Control Trial for Pain Control After Renal Transplant Surgery

Sponsor: University of California, Davis

Conditions Pain, Postoperative Transplant;Failure,Kidney
Interventions Ropivacaine Continuous Infusion Catheter Single Dose Liposomal Bupivicaine
Updated 13 times since 2018 Last updated: Feb 13, 2026 Started: Oct 4, 2018 Primary completion: Jun 12, 2026 Completion: Jun 12, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Pain, Postoperative and Transplant;Failure,Kidney and is currently actively recruiting participants. University of California, Davis leads this study, which shows 13 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Dec 2018 – ~Dec 2019 · 12 months · monthly snapshot~Dec 2019 – ~Aug 2020 · 8 months · monthly snapshot~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Mar 2022 · 6 months · monthly snapshot~Mar 2022 – ~Sep 2022 · 6 months · monthly snapshot~Sep 2022 – ~Jul 2023 · 10 months · monthly snapshot~Jul 2023 – ~Jul 2024 · 12 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – ~Apr 2025 · 4 months · monthly snapshot~Apr 2025 – ~Feb 2026 · 10 months · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshot

Change History

13 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting PHASE4

  2. Apr 2025 — Feb 2026 [monthly]

    Recruiting PHASE4

  3. Dec 2024 — Apr 2025 [monthly]

    Recruiting PHASE4

  4. Sep 2024 — Dec 2024 [monthly]

    Recruiting PHASE4

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE4

▶ Show 8 earlier versions

  1. Jul 2023 — Jul 2024 [monthly]

    Recruiting PHASE4

  2. Sep 2022 — Jul 2023 [monthly]

    Recruiting PHASE4

  3. Mar 2022 — Sep 2022 [monthly]

    Recruiting PHASE4

  4. Sep 2021 — Mar 2022 [monthly]

    Recruiting PHASE4

  5. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE4

  6. Aug 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  7. Dec 2019 — Aug 2020 [monthly]

    Recruiting PHASE4

  8. Dec 2018 — Dec 2019 [monthly]

    Recruiting PHASE4

    First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of California, Davis
Data source: University of California, Davis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations